Steven Daniel Schwartz, Director at Avalanche Biotechnologies, Inc. (AAVL), sold 91,000 shares at $55.46 ($5.0M) on 2015-01-13, disclosed to the SEC on 2015-01-15.
Open-market sale of $5.0M AAVL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AAVL | SELL | 2015-05-22 | $648K | — | Filing → |
| AAVL | SELL | 2015-05-11 | $570K | — | Filing → |
| AAVL | SELL | 2015-04-23 | $652K | — | Filing → |